(Translated by https://www.hiragana.jp/)
PIK-93 | PI4KIIIβ inhibitor | TargetMol
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

PIK-93

PIK-93
PIK-93, the first potent synthetic PI4K inhibitor, exhibits an IC50 of 19 nM and also inhibits PI3Kαあるふぁ with an IC50 of 39 nM.
Catalog No. T2616Cas No. 593960-11-3
Select Batch
Purity:97.72%
Contact us for more batch information

Resource Download

PIK-93

Catalog No. T2616Cas No. 593960-11-3

PIK-93, the first potent synthetic PI4K inhibitor, exhibits an IC50 of 19 nM and also inhibits PI3Kαあるふぁ with an IC50 of 39 nM.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Pack SizePriceAvailabilityQuantity
2 mg$29In Stock
5 mg$48In Stock
10 mg$73In Stock
25 mg$133In Stock
50 mg$223In Stock
100 mg$329In Stock
200 mg$475In Stock
1 mL x 10 mM (in DMSO)$54In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "PIK-93"

Product Introduction

Bioactivity
Description
PIK-93, the first potent synthetic PI4K inhibitor, exhibits an IC50 of 19 nM and also inhibits PI3Kαあるふぁ with an IC50 of 39 nM.
Targets&IC50
PI3Kαあるふぁ:39 nM, PI4K:19 nM
In vivo
At concentrations ranging from 0.5 μみゅーM to 1 μみゅーM, PIK-93 impairs the stability of aggregates formed in differentiated HL60 cells treated with f-Met-Leu-Phe. In COS-7 cells, 250 nM of PIK-93 effectively eliminates the accumulation of the CERT-PH domain and FL-Cer in the Golgi apparatus. Additionally, in T6.11 cells, 300 nM of PIK-93 reduces Carbachol-induced translocation of TRPC6 to the plasma membrane and subsequent Ca2+ entry. The same concentration of PIK-93 also significantly inhibits the conversion of [3H]-labeled serine to endogenous sphingomyelin, indicating the critical role of PI4KIIIβべーた in the endoplasmic reticulum and Golgi apparatus for ceramide transfer and sphingomyelin synthesis regulation. Research demonstrates that PIK-93 possesses antiviral capabilities, inhibiting replication of the poliovirus and hepatitis C virus with EC50 values of 0.14 μみゅーM and 1.9 μみゅーM, respectively. PIK-93 effectively inhibits PI3Kγがんま and PI4KIIIβべーた, with IC50 values of 16 nM and 19 nM, respectively, and other PI3K members, including PI3Kαあるふぁ, βべーた, and δでるた, with IC50 values of 39 nM, 0.59 μみゅーM, and 0.12 μみゅーM, while showing negligible inhibition effects on other kinases at concentrations up to 10 μみゅーM.
Kinase Assay
Assay of PI3Ks: IC50 values are measured using a standard TLC assay for lipid kinase activity. Kinase reactions are performed by preparing areaction mixture containing kinase, PIK-93 (2% DMSO final concentration), buffer (25 mM HEPES, pH 7.4, 10 mM MgCl2), and freshly sonicated phosphatidylinositol (100 μみゅーg/ml). Reactions are initiated by the addition of ATP containing 10 μみゅーCi of γがんま-32P-ATP to a final concentration 10 or 100 μみゅーM, and allowed to proceed for 20 min at room temperature. For TLC analysis, reactions are then terminated by the addition of 105 μみゅーL 1N HCl followed by 160 μみゅーL CHCl3:MeOH (1:1). The biphasic mixture is vortexed, briefly centrifuged, and the organic phase transferred to a new tube using a gel loading pipette tip precoated with CHCl3. This extract is spotted on TLC plates and developed for 3 hours–4 hours in a 65:35 solution of n-propanol:1M acetic acid. The TLC plates are then dried, exposed to a phosphorimager screen, and quantitated. Kinase activity is typically measured at 10–12 concentrations of PIK-93 representing two-fold dilutions from the highest concentration of 100 μみゅーM.
Cell Research
For actin staining, dHL60 cells are preincubated in suspension with PIK-93 or vehicle for 40 min, centrifuged for 5 min at 2000 rpm at room temperature in a J6-B centrifuge, resuspended in mHBSS containing the respective agent at the same concentration, allowed to stick to fibronectin-covered coverslips, and subjected to stimulation with a uniform concentration of 100 nM f-Met-Leu-Phe (fMLP) for 3 min. Cellsare fixed in 3.7% PFA and stained with 10 units/mL rhodamine-phalloidin for 15 min.(Only for Reference)
AliasPIK 93
Chemical Properties
Molecular Weight389.88
FormulaC14H16ClN3O4S2
Cas No.593960-11-3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 39 mg/mL (100 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.5649 mL12.8245 mL25.6489 mL128.2446 mL
5 mM0.5130 mL2.5649 mL5.1298 mL25.6489 mL
10 mM0.2565 mL1.2824 mL2.5649 mL12.8245 mL
20 mM0.1282 mL0.6412 mL1.2824 mL6.4122 mL
50 mM0.0513 mL0.2565 mL0.5130 mL2.5649 mL
100 mM0.0256 mL0.1282 mL0.2565 mL1.2824 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μみゅーL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μみゅーL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μみゅーL DMSOTargetMol | reagent main solution, add 300 μみゅーLPEG300TargetMol | reagent mix well and clarify, then add 50 more μみゅーL Tween 80, mix well and clarify, then add 600 more μみゅーLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μみゅーL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy PIK-93 | purchase PIK-93 | PIK-93 cost | order PIK-93 | PIK-93 chemical structure | PIK-93 in vivo | PIK-93 formula | PIK-93 molecular weight